International Patent: COMBINATION THERAPY COMPRISING AN RNA CANCER VACCINE AND A MULTISPECIFIC BINDING AGENT TARGETING PD-1/PD-L1 AND VEGF/VEGFR FOR CANCER TREATMENT

GENEVA, July 18 -- BIONTECH SE filed a patent application (EP2026/050601) for “COMBINATION THERAPY COMPRISING AN RNA CANCER VACCINE AND A MULTISPECIFIC BINDING AGENT TARGETING PD-1/PD-L1 AND VEGF/VEGFR FOR CANCER TREATMENT”. With publication no. WO/2026/150132, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....